Monday, February 26, 2024
4.8 C
HomeBeefNew one-step lateral flow test to enable rapid diagnosis of pneumonia in...
Catherina Cunnane
Catherina Cunnane
Catherina Cunnane hails from a sixth-generation drystock and specialised pedigree suckler enterprise in Co. Mayo. She currently holds the positions of editor and general manager at That's Farming, having joined the firm during its start-up phase in 2015.
Reading Time: 2 minutes

New one-step lateral flow test to enable rapid diagnosis of pneumonia in calves

A new one-step rapid test – which could detect the causative agents of pneumonia in calves – is in development.

A consortium, led by the University of Surrey’s School of Veterinary Medicine, is developing a new molecular lateral flow test to enable rapid diagnosis of pneumonia in calves.

The new test, known as RaDiCal, will improve disease management and lead to faster treatment of impacted animals, researchers believe.


According to the researchers involved in the BBSRC-funded project, RaDiCal will allow vets to input samples into a portable device and quickly generate results and diagnoses of calves – allowing farmers to take quick action to limit the spread of infection.

The test is a pioneering molecular lateral flow platform, which can be linked to a mobile phone digital platform for easy interpretation of results, which can be yielded in under 30 minutes, it is believed.

The RaDiCal project is a collaboration with experts from Global Access Diagnostics, the University of Glasgow, Cardiff University, and Westpoint Farm Vets.

About GADx

Global Access Diagnostics (GADx) is a leading developer and manufacturer of advanced lateral flow and rapid diagnostic technologies.

Leveraging its core technology platforms, it works with governments and international organisations, reinvesting our profits to deliver “high-quality and affordable” diagnostics for everyone.

As a CRMO, GADx offers world-leading expertise for contract research and development as well as helping companies to scale up manufacturing (prototyping to pilot-scale) with the capacity to produce over 2 million tests per day.

It then facilitates local manufacturing and/or onward distribution throughout the world, with a focus on low- and middle-income countries.

GADx is a Global Access Health (GAH) company and combines expertise in rapid diagnostics development from Mologic Ltd with low-cost manufacturing and scale-up capability of sister company, Global Access Diagnostics (GAD).

It is headquartered in Bedford in the United Kingdom and has a US subsidiary, Mologic Inc. situated in Maine, New Gloucester.

Last year, That’s Farming published an article on the roll-out of a new PCR to identify TB infection “more quickly and simply” in the UK, which you can read about via this link.

- Advertisment -

Most Popular